COULD YOU HAVE SEEN ELI LILLY’S (LLY) RALLY COMING? HERE’S HOW WE DID.
By Nigam Arora
On October 17th, our paid members were alerted that a major development on weight loss drug pricing was likely coming and that it could significantly impact Eli Lilly (LLY) stock.
Yesterday, there was a signal in ZYX Buy on a key development that could materially impact LLY stock.
Eli Lilly, one of the stocks in the ZYX Buy Core Model Portfolio by The Arora Report, has struck a deal with President Trump’s administration to lower the price of its weight loss drugs. Reduced pricing and expanded access, particularly through Medicare and Medicaid, are expected to drive significantly wider adoption of Lilly’s GLP-1/obesity treatments.… Please click here or the title below to read more.
November 13, 2025